The markets closed mixed with the Dow adding 15 points to 12,965 over concerns that the Greek economy will remain in a prolonged recession. Nasdaq slipped 3 points to 2948.

On the upside

Shareholders approved the merger of Eldorado Gold (NYSE: EGO) with European Goldfields.

FuelCell Energy (Nasdaq: FCEL) rose on speculation that the company may supply fuel cells for Apple's (Nasdaq: AAPL) solar powered data center in North Carolina.

Shares of Polypore International (NYSE: PPO) advanced ahead of its earnings release tomorrow.

On the downside

The Food and Drug Administration suspended drug trials of GTx's (Nasdaq: GTXI) prostate cancer treatment Capesaris due to an increased risk of bloom clots.

FDATracker.com expects the Food and Drug Administration to reject Vivus' (Nasdaq: VVUS) obesity treatment Qnexa.

Boyd Gaming (NYSE: BYD) narrowed fourth quarter losses but the results fell short of analyst expectations.

In the broad market, declining issues outpaced advancers by a slim margin on the NYSE and by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 5 points to 823.